Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique

BACKGROUND: The monovalent type 2 oral poliovirus vaccine (mOPV2) stockpile is low. One potential strategy to stretch the existing mOPV2 supply is to administer a reduced dose: 1 drop instead of 2. METHODS: We conducted a randomized, controlled, open-label, noninferiority trial (10% margin) to compa...

Descripción completa

Detalles Bibliográficos
Autores principales: de Deus, Nilsa, Capitine, Igor Paulo Ubisse, Bauhofer, Adilson Fernando Loforte, Marques, Selma, Cassocera, Marta, Chissaque, Assucênio, Bero, Diocreciano Matias, Langa, José Paulo, Padama, Fernando Manuel, Jeyaseelan, Visalakshi, Oberste, M Steven, Estivariz, Concepcion F, Verma, Harish, Jani, Ilesh, Mach, Ondrej, Sutter, Roland W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400415/
https://www.ncbi.nlm.nih.gov/pubmed/33180924
http://dx.doi.org/10.1093/infdis/jiaa704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400415/
https://www.ncbi.nlm.nih.gov/pubmed/33180924
http://dx.doi.org/10.1093/infdis/jiaa704

Ejemplares similares